Why Allergan (AGN) Stock Soared in After Market Trading Today

NEW YORK (TheStreet) -- Allergan  (AGN) soared in after-hours trading on Monday amid news that activist investor William Ackman and Valeant Pharmaceuticals International have joined forces to pursue a takeover of the health care company.

Ackman is the founder and CEO of hedge fund Pershing Square Capital Management, which has built an almost 10% stake in Allergan, according to CNBC. The company is worth approximately $4 billion.

Allergan closed at $142, an all-time high, and then surged 19% after the market closed. More than 9 million shares changed hands, more than triple the average volume of 2,944,310. 

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AGN Chart

AGN data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

More from Markets

5 Stocks That Are Screaming Buys Right Now

5 Stocks That Are Screaming Buys Right Now

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

European Union Says Tariffs on U.S. Imports Will Kick In on June 22

Stocks Rise, GE Dropped From the Dow, Starbucks, Oracle - 5 Things You Must Know

Stocks Rise, GE Dropped From the Dow, Starbucks, Oracle - 5 Things You Must Know

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge

Global Stocks Rebound But US-China Trade War Concerns Keep Investors on Edge